Catalyst Pharmaceuticals, Inc. (DELISTED) (CPRX:DL)
31.49
0.00 (0.00%)
USD |
NASDAQ |
Jul 24, 16:00
Catalyst Pharmaceuticals Debt to Equity Ratio : 0.0026 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.0026 |
| December 31, 2025 | 0.0029 |
| September 30, 2025 | 0.0031 |
| June 30, 2025 | 0.0035 |
| March 31, 2025 | 0.0039 |
| December 31, 2024 | 0.0044 |
| September 30, 2024 | 0.005 |
| June 30, 2024 | 0.0055 |
| March 31, 2024 | 0.0062 |
| December 31, 2023 | 0.0092 |
| September 30, 2023 | 0.0105 |
| June 30, 2023 | 0.0099 |
| March 31, 2023 | 0.0114 |
| December 31, 2022 | 0.013 |
| September 30, 2022 | 0.0147 |
| June 30, 2022 | 0.0168 |
| March 31, 2022 | 0.0187 |
| December 31, 2021 | 0.0203 |
| September 30, 2021 | 0.0214 |
| June 30, 2021 | 0.0225 |
| March 31, 2021 | 0.0238 |
| December 31, 2020 | 0.0002 |
| September 30, 2020 | 0.0007 |
| June 30, 2020 | 0.0018 |
| March 31, 2020 | 0.0088 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.0108 |
| September 30, 2019 | 0.0131 |
| June 30, 2019 | 0.0172 |
| March 31, 2019 | 0.0055 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Inovio Pharmaceuticals, Inc. | 1.831 |
| Indivior Pharmaceuticals, Inc. | -2.447 |
| Exelixis, Inc. | 0.09 |
| United Therapeutics Corp. | 0.00 |
| Krystal Biotech, Inc. | 0.0065 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.148B |
| Total Liabilities (Quarterly) | 134.91M |
| Shareholders Equity (Quarterly) | 1.013B |
| Current Ratio | 7.103 |
| Net Debt Paydown Yield | 0.00% |